Skip to main content

3 Result(s)

within Article Remove this filter Ellie Edlmann Remove this filter Biomedicine, general Remove this filter

and

  1. Article

    Open Access

    Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma

    The incidence of chronic subdural haematoma (CSDH) is increasing. Although surgery remains the mainstay of management for symptomatic patients, uncertainty remains regarding the role of steroids. Hence, the De...

    Annabel Allison, Ellie Edlmann, Angelos G. Kolias, Carol Davis-Wilkie, Harry Mee… in Trials (2019)

    Download PDF (495 KB) View Article

  2. Article

    Open Access

    Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial

    After publication of the original article [1], the authors notified that that one of the BNTRC institutional collaborator names was misspelled.

    Angelos G. Kolias, Ellie Edlmann, Eric P. Thelin, Diederik Bulters… in Trials (2019)

    Download PDF (247 KB) View Article

  3. Article

    Open Access

    Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial

    Chronic subdural haematoma (CSDH) is a common neurosurgical condition, typically treated with surgical drainage of the haematoma. However, surgery is associated with mortality and morbidity, including up to 20...

    Angelos G. Kolias, Ellie Edlmann, Eric P. Thelin, Diederik Bulters… in Trials (2018)

    Download PDF (621 KB) View Article